← Back to Patent Explorer
US3110716A Expired / Lapsed US ⏱️ 0.0 years remaining

Derivatives of 3, 6-disubstituted-7-sulfamylbenzothiadiazine dioxides

Assignee: Pfizer Inc
•
Filing: 1958-02-17
•
Granted: 1963-11-12
•
Expires: 1978-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 William M Mclamore
  • 👤 Gerald D Laubach

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 02:27
CPC Classifications
C; C07; C07D; C07D285/00; C07D285/15; C07D285/16; C07D285/18; C07D285/20; C07D285/22; C07D285/24; C07D285/26; C07D285/30

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 24 words
THE AMPHOERIC COMPOUND AND THE PHARMACOLOGICALLY ACCEPTABLE ACID AND BASE ADDITION SALTS THEREOF, SAID COMPOUND BEING SELECTED FROM THE GROUP REPRESENTED BY THE FORMULAE:
Claim 2
Dependent Claim 24 words
THE AMPHOERIC COMPOUND AND THE PHARMACOLOGICALLY ACCEPTABLE ACID AND BASE ADDITION SALTS THEREOF, SAID COMPOUND BEING SELECTED FROM THE GROUP REPRESENTED BY THE FORMULAE:

References Cited (Backward Citations)

US2809194A Cited
US2169971A Cited
US2289029A Cited
US2117260A Cited
US2910476A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1966-11-11 1967-05-13 1967-11-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1970-11-11 1971-05-13 1971-11-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1974-11-11 1975-05-13 1975-11-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag